Page last updated: 2024-08-21

indazoles and stilbenes

indazoles has been researched along with stilbenes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Cai, X; Duan, JX; Hart, C; Lan, L; Matteucci, M; Meng, F1
Chang, G; Chang, S; Chen, G; Dai, B; Gao, L; Hu, L; Li, B; Shi, J; Sun, X; Xiao, W; Xie, B; Xie, Y; Xu, Z; Yu, D; Zhang, Y; Zhu, W1
Chuang, TH; Hsu, LC; Lai, CY; Lin, KI; Su, YW1
Banerjee, S; Clamp, AR; Dive, C; Hall, M; Hasan, J; Jayson, GC; Lyon, AR; Morgan, RD; Orbegoso, C; Rustin, GJS; Taylor, S; Tugwood, J; Zhou, C1
Allen, JE; Casaravilla, C; Díaz, Á; Pittini, Á; Rückerl, D1
Chen, Y; Han, X; Li, G; Ma, Z; Zhang, W1

Reviews

1 review(s) available for indazoles and stilbenes

ArticleYear
Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.
    Journal of immunology research, 2017, Volume: 2017

    Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Cytokines; Dermatitis; Endosomes; Humans; Imiquimod; Indazoles; Isonicotinic Acids; Mice; Psoriasis; Resveratrol; Signal Transduction; Skin; Stilbenes; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptor 9; Toll-Like Receptors

2017

Trials

1 trial(s) available for indazoles and stilbenes

ArticleYear
Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial.
    Gynecologic oncology, 2020, Volume: 156, Issue:3

    Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cardiotoxicity; Dose-Response Relationship, Drug; Female; Humans; Indazoles; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Ovarian Neoplasms; Progression-Free Survival; Pyrimidines; Stilbenes; Sulfonamides; Survival Rate

2020

Other Studies

4 other study(ies) available for indazoles and stilbenes

ArticleYear
Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
    Journal of medicinal chemistry, 2007, Mar-08, Volume: 50, Issue:5

    Topics: Acetylene; Animals; Binding Sites; Binding, Competitive; Cattle; Cell Line, Tumor; Colchicine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Indazoles; Radioligand Assay; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2007
Pterostilbene Induces Cell Apoptosis and Cell Cycle Arrest in T-Cell Leukemia/Lymphoma by Suppressing the ERK1/2 Pathway.
    BioMed research international, 2017, Volume: 2017

    Topics: Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Humans; Indazoles; Jurkat Cells; Leukemia, T-Cell; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Phosphorylation; Piperazines; Reactive Oxygen Species; Stilbenes

2017
Activation of the NLRP3 Inflammasome by Particles from the Echinococcus granulosus Laminated Layer.
    Infection and immunity, 2020, 08-19, Volume: 88, Issue:9

    Topics: Amino Acid Chloromethyl Ketones; Animals; Bone Marrow Cells; Caspase 1; Cell-Derived Microparticles; Dendritic Cells; Echinococcus granulosus; Female; Gene Expression Regulation; Host-Parasite Interactions; Indazoles; Inflammasomes; Interleukin-12; Interleukin-1beta; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Phagocytosis; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction; Stilbenes; Sulfonamides; Wortmannin

2020
Design, Synthesis, and Cytotoxic Activities of Indole and Indazole-Based Stilbenes.
    Chemistry & biodiversity, 2023, Volume: 20, Issue:5

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Indazoles; Indoles; Molecular Structure; Stilbenes; Structure-Activity Relationship

2023